-
HPV vaccine slashes rate of infection by 86% in UK
pharmafile
June 22, 2018
Since the introduction of the vaccination against the Human Papilloma Virus in 2008, there has been an 86% drop in the incidence of infection in women aged 16 to 21.
-
Elderly cancer cases to increase 80% by 2035, says CRUK
pharmafile
June 22, 2018
A new report from Cancer Research UK has indicated that the number of UK citizens over the age of 75 with cancer is predicted to rise by up to 80% by the year 2035.
-
UK announces review of medicinal cannabis
pharmatimes
June 21, 2018
Home secretary Sajid Javid has announced a review of medicinal cannabis in the UK, in response to growing pressure to allow use of cannabis oil to help control seizures in children with severe forms of epilepsy.
-
Pancreatic cancer survival much lower than thought, research finds
pharmatimes
June 21, 2018
Pancreatic Cancer UK is calling for greater investment in research funding for pancreatic cancer as new data reveals that just three percent of patients with the most common form will survive beyond five years.
-
Recipharm to buy Sanofi inhalation contract business and plant in U.K. for $60M
fiercepharma
June 14, 2018
Recipharm has struck a deal with Sanofi to buy the French drugmaker’s contract inhalation drug business and plant in the U.K., picking up new capabilities and clients in the process.
-
Fully automated facility for drug discovery to be built in UK
pharmatimes
June 13, 2018
The UK Government has revealed plans to build a fully automated facility at the Rosalind Franklin Institute in Oxfordshire to enable fast, effective and hands-free molecular discovery for new medicines.
-
UK and Chinese scientists partner on new medicines for epidemics
pharmaceutical-technology
June 13, 2018
Researchers at the University of Birmingham, UK, are collaborating with scientists from China’s Guangzhou Institutes of Biomedicine and Health (GIBH) to develop new medicines for treating global epidemics.
-
Emergex Awarded Innovate UK Grant to Progress its Universal and Pandemic Flu Vaccine
b3cnewswire.
June 04, 2018
Emergex Vaccines Holding Limited (‘Emergex’), a biotechnology company pioneering a new approach to vaccine development in the field of infectious diseases
-
UK streams £30m into global fight against AMR
pharmatimes
May 24, 2018
The funding will be delivered through four new projects as part of the Global AMR Innovation Fund (GAMRIF), which will primarily benefit people in low- and middle-income countries, where the burden of infection is greatest.
-
To treat corneal blindness Atelerix Ltd (UK) and LV Prasad Eye Institute (India) unites
biospectrumasia
May 08, 2018
It overcomes the problems presented by the current need for cryo-shipping as it is simple, cell-friendly and user-friendly, and offers immediate access to cell therapies